Product Description: Cantuzumab is a monoclonal antibody that can binds the CanAg antigen. Cantuzumab is typically linked to one of several cytotoxic agents, yielding antibody-drug conjugates (ADC), such as Cantuzumab mertansine (HY-P99492) and Cantuzumab ravtansine (HY-P99493)[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Xie H, et al. Pharmacokinetics and biodistribution of the antitumor immunoconjugate, cantuzumab mertansine (huC242-DM1), and its two components in mice. J Pharmacol Exp Ther. 2004 Mar;308(3):1073-82.
CAS Number: 1204740-23-7
Molecular Weight: N/A
Compound Purity: 99.00
Research Area: Cancer
Solubility: H2O
Target: ADC Antibody